Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 150 entries
View as:

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01625897 Org: User:
Start: 05/31/12 End: 03/31/15 Due: 03/31/16

Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00707954 Org: User:
Start: 06/30/08 End: 02/28/09 Due: 02/28/10

Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants

Phase: N/A Priority: Normal
NCT ID: NCT03507738 Org: User:
Start: 07/03/18 End: 06/28/19 Due: 06/28/20

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01072331 Org: User:
Start: 02/28/10 End: 08/31/10 Due: 08/31/11

An Exploratory Study of MT-2990 in Patients With AAV

Phase: N/A Priority: Normal
NCT ID: NCT06196905 Org: User:
Start: 06/24/24 End: 02/28/26 Due: 02/28/27

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT00805766 Org: User:
Start: 12/31/08 End: 07/31/10 Due: 07/31/11

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Phase: N/A Priority: Normal
NCT ID: NCT00500682 Org: User:
Start: 07/31/07 End: 10/31/11 Due: 10/31/12

Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology Study

Phase: N/A Priority: Normal
NCT ID: NCT00147303 Org: User:
Start: 04/30/04 End: 01/31/05 Due: 01/31/06

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00330681 Org: User:
Start: 05/31/06 End: 09/30/08 Due: 09/30/09

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT05123196 Org: User:
Start: 11/16/21 End: 11/08/22 Due: 11/08/23

Exploratory Clinical Study of MT-2301

Phase: N/A Priority: Normal
NCT ID: NCT02140047 Org: User:
Start: 04/30/14 End: 09/30/15 Due: 09/30/16

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Phase: N/A Priority: Normal
NCT ID: NCT00501046 Org: User:
Start: 07/31/07 End: 10/31/11 Due: 10/31/12

Safety and Tolerability Study of MCI-196

Phase: N/A Priority: Normal
NCT ID: NCT01818687 Org: User:
Start: 08/31/13 End: 12/31/14 Due: 12/31/15

Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT00059644 Org: User:
Start: 07/31/01 End: 06/30/04 Due: 06/30/05

Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00147316 Org: User:
Start: 04/30/02 End: 09/30/03 Due: 09/30/04

A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01626885 Org: User:
Start: 05/31/12 End: 06/30/14 Due: 06/30/15

Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02220907 Org: User:
Start: 08/31/14 End: 02/29/16 Due: 02/28/17

Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00780416 Org: User:
Start: 11/30/08 End: 08/31/10 Due: 08/31/11

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03289234 Org: User:
Start: 11/16/16 End: 07/24/18 Due: 07/24/19

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Phase: N/A Priority: Normal
NCT ID: NCT00772382 Org: User:
Start: 12/31/08 End: 08/31/10 Due: 08/31/11

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III

Phase: N/A Priority: Normal
NCT ID: NCT00415519 Org: User:
Start: 12/31/06 End: 07/31/08 Due: 07/31/09

Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)

Phase: N/A Priority: Normal
NCT ID: NCT02923154 Org: User:
Start: 09/30/16 End: 04/30/19 Due: 04/30/20

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02227849 Org: User:
Start: 08/31/14 End: 03/31/16 Due: 03/31/17

Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions

Phase: N/A Priority: Normal
NCT ID: NCT01532570 Org: User:
Start: 01/31/12 End: 05/31/14 Due: 05/31/15

Comparative Oral Bioavailability Study of MT-1303

Phase: N/A Priority: Normal
NCT ID: NCT02310048 Org: User:
Start: 11/30/14 End: 03/31/15 Due: 03/31/16